142 related articles for article (PubMed ID: 7147996)
1. Differential effects of 3-methylcholanthrene and phenobarbitone treatment on the oxidative metabolism of antipyrine in vitro by microsomal fractions of rat liver.
Kahn GC; Boobis AR; Murray S; Davies DS
Xenobiotica; 1982 Aug; 12(8):509-16. PubMed ID: 7147996
[TBL] [Abstract][Full Text] [Related]
2. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.
Danhof M; Krom DP; Breimer DD
Xenobiotica; 1979 Nov; 9(11):695-702. PubMed ID: 119355
[TBL] [Abstract][Full Text] [Related]
3. The effect of age on the oxidative metabolism of antipyrine by uninduced microsomal fractions of rat liver.
Van Geel CA; Van Bezooijen CF
Mech Ageing Dev; 1990 Apr; 53(2):169-77. PubMed ID: 2342384
[TBL] [Abstract][Full Text] [Related]
4. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
Szakács T; Veres Z; Vereczkey L
Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
[TBL] [Abstract][Full Text] [Related]
5. Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo.
Teunissen MW; Joeres RP; Vermeulen NP; Breimer DD
Xenobiotica; 1983 Apr; 13(4):223-31. PubMed ID: 6624137
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the effects of pretreatment with phenobarbitone and 3-methylcholanthrene on the metabolism of aflatoxin B1 by rat liver microsomes and isolated hepatocytes in vitro.
Metcalfe SA; Colley PJ; Neal GE
Chem Biol Interact; 1981 May; 35(2):145-57. PubMed ID: 6783328
[TBL] [Abstract][Full Text] [Related]
7. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
[TBL] [Abstract][Full Text] [Related]
8. Influence of cigarette smoke on antipyrine metabolite formation in rats.
Nakagawa A; Chiba K; Ishizaki T; Nakamura K
Res Commun Chem Pathol Pharmacol; 1983 Sep; 41(3):473-91. PubMed ID: 6635330
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of metronidazole and antipyrine in isolated rat hepatocytes. Influence of sex and enzyme induction and inhibition.
Loft S; Poulsen HE
Biochem Pharmacol; 1989 Apr; 38(7):1125-36. PubMed ID: 2706012
[TBL] [Abstract][Full Text] [Related]
10. Effects of phenobarbital, dexamethasone, and 3-methylcholanthrene administration on the metabolism of 17 beta-estradiol by liver microsomes from female rats.
Suchar LA; Chang RL; Thomas PE; Rosen RT; Lech J; Conney AH
Endocrinology; 1996 Feb; 137(2):663-76. PubMed ID: 8593816
[TBL] [Abstract][Full Text] [Related]
11. Studies on the metabolism of aminopyrine, antipyrine and theophylline using monoclonal antibodies to cytochrome P-450 isozymes purified from rat liver.
Slusher LB; Park SS; Gelboin HV; Vesell ES
Biochem Pharmacol; 1987 Jul; 36(14):2359-67. PubMed ID: 2440440
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man.
Boobis AR; Brodie MJ; Kahn GC; Toverud EL; Blair IA; Murray S; Davies DS
Br J Clin Pharmacol; 1981 Dec; 12(6):771-7. PubMed ID: 7340879
[TBL] [Abstract][Full Text] [Related]
13. The effect of age on antipyrine metabolism by liver microsomes isolated from phenobarbital-treated rats.
Henderson DJ; van Bezooijen CF
Mech Ageing Dev; 1989 Sep; 49(3):287-94. PubMed ID: 2811495
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of antipyrine and m-xylene in rats after prolonged pretreatment with xylene alone or xylene with ethanol, phenobarbital or 3-methylcholanthrene.
Elovaara E; Engström K; Häyri L; Hase T; Aitio A
Xenobiotica; 1989 Sep; 19(9):945-60. PubMed ID: 2815836
[TBL] [Abstract][Full Text] [Related]
15. The effect of malaria infection on antipyrine metabolite formation in the rat.
Mansor SM; Ward SA; Edwards G
Biochem Pharmacol; 1991 Apr; 41(8):1264-6. PubMed ID: 2009102
[TBL] [Abstract][Full Text] [Related]
16. Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in rats.
Teunissen MW; Van Graft M; Vermeulen NP; Breimer DD
Xenobiotica; 1983 Aug; 13(8):497-502. PubMed ID: 6649682
[TBL] [Abstract][Full Text] [Related]
17. Studies on in vitro antipyrine metabolism by 13C,15N double labeled method.
Nakagawa A; Nakamura K; Maeda K; Kamataki T; Kato R
Life Sci; 1987 Jul; 41(2):133-43. PubMed ID: 3298908
[TBL] [Abstract][Full Text] [Related]
18. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample.
Loft S; Nielsen AJ; Borg BE; Poulsen HE
Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365
[TBL] [Abstract][Full Text] [Related]
19. The effects of hepatic microsomal enzyme inducers on the pharmacokinetics of ouabain after portal and systemic administration to rats.
Thompson TN; Klaassen CD
J Pharm Pharmacol; 1995 Dec; 47(12A):1041-7. PubMed ID: 8932692
[TBL] [Abstract][Full Text] [Related]
20. The effect of indomethacin on hepatic drug-oxidizing capacity in the rat: trimethadione and antipyrine metabolism as an indicator.
Tanaka E; Kobayashi S; Aramphongphan A; Kurata N; Oguchi K; Kuroiwa Y; Yasuhara H
J Pharmacobiodyn; 1985 Sep; 8(9):773-9. PubMed ID: 4087137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
